Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: GlaxoSmithKline
Current Parent CompanyGlaxoSmithKline
Parent at the Time of the Penalty Announcement subscribe to see this data field
Penalty: $1,270,000
Year: 2023
Date: July 14, 2023
Offense Group: competition-related offenses
Primary Offense: price-fixing or anti-competitive practices
Secondary Offense: consumer protection violation
Violation Description: The company, GlaxoSmithKline, allegedly engaged in years-long delay tactics to prevent competitors from being able to go to market with generic versions of Flonase, a corticosteroid nasal spray €šÂ¬Ãƒ€¦Ã‚¡Ã‚¬Ã¢€š¬Ã…¡Ã‚¬Ã‚ effectively forcing Hoosiers and other consumers to pay more for the drug by maintaining a monopoly.
Level of Government: state
Action Type: agency action
Agency: Indiana Attorney General
Civil or Criminal Case: civil
Facility State: Indiana
HQ Country of Current Parent: United Kingdom
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data(click here)
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.